Public health activists say unless drug recall policy with legal backing is brought in, guidelines will not serve any purpose; ask who has ultimate authority to verify all batches are recalled.
Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.
Organisation of Pharmaceutical Producers of India seeks nod for drugs to be marketed at same time as US, Europe. But regulator rarely permits a drug launch without local clinical trials.
India's apex drug regulator will form a panel to examine whether more regulatory restrictions should be put in place. Experts say more curbs a good idea but implementation is key.
CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.
The Central Drugs Standard Control Organisation has formed an inquiry committee following a complaint by ophthalmologist and ex-parliamentarian Dr Vikas Mahatme.
WHO alerted Indian authorities of possible link between the deaths and four cough and cold medicines made by Sonepat-based Maiden Pharmaceuticals on 29 September, it is learnt.
The Drug Controller General of India has in the past rejected several applications from other drugmakers, including Dr Reddy Laboratory and Natco Pharma.
China and India are home to 1.2 billion young people. They’re the pioneers in advancing the rejuvenation of the Chinese nation and realising the vision of ‘Viksit Bharat 2047’.
The countries signed a memorandum for co-development of UNICORN masts in November 2024. India has been second Asian nation to have such an agreement with Tokyo, after Philippines.
COMMENTS